What You Should Know:
- Fimlab Laboratories, a provider of laboratory services, research, and training, has announced a partnership with Proscia, a global leader in AI-enabled pathology solutions.
- This collaboration will leverage Proscia's software platform to enhance Fimlab's digital pathology capabilities and drive more precise results.
The Benefits of Digital Pathology
Digital pathology is transforming the way pathologists analyze tissue samples. By transitioning to
Read More
Digital Pathology
Paige Unveils AI Co-Pilot for Pathology & Oncology, Paige Alba
What You Should Know:
- Paige, a provider of next-generation artificial intelligence has introduced Paige Alba, a groundbreaking clinical-grade multimodal co-pilot designed to transform personalized medicine and precision oncology.
- Leveraging the power of Paige's Foundation Models, Alba delivers real-time AI-driven patient insights, marking a significant step towards Artificial General Intelligence (AGI).
A Cohesive Solution for Personalized Medicine
Paige Alba
Read More
PathAI’s AISight Dx Receives CE Mark for Primary Diagnosis
What You Should Know:
- PathAI, a pioneer in AI-powered digital pathology, has achieved a significant milestone with the CE mark certification of its AISight Dx Image Management System (IMS) for primary diagnosis.
- The certification paves the way for PathAI's expansion into the European diagnostic pathology market, offering pathologists a powerful tool to enhance their interpretations and improve laboratory efficiency.
AISight Dx: A Comprehensive Digital Pathology
Read More
PathAI Introduces AI-Based Measurement for MASH Scoring
What You Should Know:
- PathAI, a leader in AI-powered digital pathology solutions, announced today the launch of AIM-MASH on its AISight Image Management System (IMS).
- The new product offers advanced AI-based measurement tools to support pathologists in assessing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) using the MASH Clinical Research Network (CRN) Activity Score.
AIM-MASH Integration with AISight
By integrating AIM-MASH with AISight, PathAI
Read More
Clarapath Secures $36M to Automate Pathology Labs with AI-Powered Robotics
What You Should Know:
- Clarapath, a leading medical robotics company raises $36M in its Series B-1 round led by Northwell Ventures with participation from strategic players like Mayo Clinic and Ochsner Ventures, bringing Clarapath's total funding to $75M.
- The company is on a mission to modernize and transform pathology labs through automation and robotics.
The Pathology Challenge: Backlog, Labor Shortages, and Manual Processes
Pathology, the microscopic examination of
Read More
PathAI Unveils New AI-Powered Pathology Tools for Cancer Research
What You Should Know:
- PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights.
- The product pairing provides unprecedented single-cell and spatial resolution of
Read More
Providence, Microsoft, UW Develop AI-Powered Pathology Model
What You Should Know:
- A collaborative effort between Providence, Microsoft, and the University of Washington has yielded a breakthrough in cancer diagnostics with the development of an AI-powered pathology model, Prov-GigaPath.
- Prov-GigaPath is an AI-powered pathology model designed to improve patient care and transform cancer diagnostics. It analyzes entire pathology slides to identify patterns, leading to more accurate mutation predictions and effective cancer subtyping. The
Read More
PathAI Unveils AI Foundation Model Built for Disease Detection
What You Should Know:
- PathAI, a leader in the field of AI-powered pathology, has announced the launch of Pathology Universal Transformer (PLUTO), a foundation model specifically designed for the intricacies of pathology, promising to transform the development of AI tools for biopharmaceutical companies and pathology labs.
- In the realm of machine learning, foundation models (FMs) play a crucial role. These models are trained on vast amounts of unlabeled data using a technique
Read More
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis
What You Should Know:
- Quest Diagnostics today announced it will acquire key assets of PathAI Diagnostics, including its state-of-the-art digital pathology laboratory in Memphis, Tennessee.
- As part of the acquisition, this facility will become Quest's AI and digital R&D center, supporting its pathology businesses, AmeriPath, and Dermpath Diagnostics.
Digital Pathology and AI Integration
Quest will license PathAI's AISight™ digital pathology system and AI
Read More
Clarapath and Mayo Clinic Partner to Modernize Pathology Labs with Robotics, AI & Automation
What You Should Know:
- Clarapath, a medical robotics company on a mission to transform tissue processing in pathology labs, has announced a strategic collaboration with Mayo Clinic, a world-renowned leader in medical care and research.
- The strategic partnership marks a significant step towards a new era of automation and efficiency within pathology labs.
The Challenge: Manual Processes and Rising Demands
For decades, pathology labs have relied on manual,
Read More
